Literature DB >> 24029235

SnapShot: Prostate cancer.

Lamont J Barlow1, Michael M Shen.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 24029235     DOI： 10.1016/j.ccr.2013.08.033

Source DB:  PubMed          Journal:  Cancer Cell        ISSN： 1535-6108            Impact factor:   31.743


× No keyword cloud information.
  12 in total

1.  Inactivation of the Wnt/β-catenin signaling pathway underlies inhibitory role of microRNA-129-5p in epithelial-mesenchymal transition and angiogenesis of prostate cancer by targeting ZIC2.

Authors:  Zhenming Jiang; Yuxi Zhang; Xi Chen; Pingeng Wu; Dong Chen
Journal:  Cancer Cell Int       Date:  2019-10-21       Impact factor: 5.722

2.  O-GlcNAcylation modulates Bmi-1 protein stability and potential oncogenic function in prostate cancer.

Authors:  Y Li; L Wang; J Liu; P Zhang; M An; C Han; Y Li; X Guan; K Zhang
Journal:  Oncogene       Date:  2017-07-17       Impact factor: 9.867

3.  Ribonuclease 4 is associated with aggressiveness and progression of prostate cancer.

Authors:  Nil Vanli; Jinghao Sheng; Shuping Li; Zhengping Xu; Guo-Fu Hu
Journal:  Commun Biol       Date:  2022-06-25

4.  Complex-I Alteration and Enhanced Mitochondrial Fusion Are Associated With Prostate Cancer Progression.

Authors:  Julie V Philley; Anbarasu Kannan; Wenyi Qin; Edward R Sauter; Mitsuo Ikebe; Kate L Hertweck; Dean A Troyer; Oliver J Semmes; Santanu Dasgupta
Journal:  J Cell Physiol       Date:  2015-11-24       Impact factor: 6.384

Review 5.  MicroRNAs and epithelial-mesenchymal transition in prostate cancer.

Authors:  Kirandeep Sekhon; Nathan Bucay; Shahana Majid; Rajvir Dahiya; Sharanjot Saini
Journal:  Oncotarget       Date:  2016-10-11

6.  MEIS-mediated suppression of human prostate cancer growth and metastasis through HOXB13-dependent regulation of proteoglycans.

Authors:  Calvin VanOpstall; Srikanth Perike; Hannah Brechka; Marc Gillard; Sophia Lamperis; Baizhen Zhu; Ryan Brown; Raj Bhanvadia; Donald J Vander Griend
Journal:  Elife       Date:  2020-06-18       Impact factor: 8.140

7.  Comprehensive metabolomics analysis of prostate cancer tissue in relation to tumor aggressiveness and TMPRSS2-ERG fusion status.

Authors:  Ilona Dudka; Elin Thysell; Kristina Lundquist; Henrik Antti; Diego Iglesias-Gato; Amilcar Flores-Morales; Anders Bergh; Pernilla Wikström; Gerhard Gröbner
Journal:  BMC Cancer       Date:  2020-05-18       Impact factor: 4.430

Review 8.  The role of mRNA splicing in prostate cancer.

Authors:  Anna V Lapuk; Stanislav V Volik; Yuzhuo Wang; Colin C Collins
Journal:  Asian J Androl       Date:  2014 Jul-Aug       Impact factor: 3.285

9.  Novel tumor suppressor microRNA at frequently deleted chromosomal region 8p21 regulates epidermal growth factor receptor in prostate cancer.

Authors:  Nathan Bucay; Kirandeep Sekhon; Shahana Majid; Soichiro Yamamura; Varahram Shahryari; Z Laura Tabatabai; Kirsten Greene; Yuichiro Tanaka; Rajvir Dahiya; Guoren Deng; Sharanjot Saini
Journal:  Oncotarget       Date:  2016-10-25

10.  Inhibition of ANO1/TMEM16A induces apoptosis in human prostate carcinoma cells by activating TNF-α signaling.

Authors:  Yan Song; Jian Gao; Lizhao Guan; Xiaoling Chen; Jianjun Gao; KeWei Wang
Journal:  Cell Death Dis       Date:  2018-06-13       Impact factor: 8.469
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.